|
1
|
Kotsiri I, Resta P, Spyrantis A, Panotopoulos C, Chaniotis D, Beloukas A and Magiorkinis E: Viral infections and schizophrenia: A comprehensive review. Viruses. 15(1345)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maisarah A, Mohamad S, Husain M, Abdullah S and Noordin R: Association between infection with Toxoplasma gondii and psychiatric disorders. Folia Parasitol (Praha). 69(2022.008)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kim K and Weiss LM: Toxoplasma: The next 100 years. Microbes Infect. 10:978–984. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bisetegn H, Debash H, Ebrahim H, Mahmood N, Gedefie A, Tilahun M, Alemayehu E, Mohammed O and Feleke DG: Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta-analysis. Health Sci Rep. 6(e1319)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Flegr J: Effects of Toxoplasma on human behavior. Schizophr Bull. 33:757–760. 2007.
|
|
6
|
Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, Brunovsky M, Bubenikova-Valesova V, Holub D, Palenicek T and Höschl C: Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: Voxel-based-morphometry (VBM) study. World J Biol Psychiatry. 13:501–509. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, De Wit LA, VanWormer E and Villena I: Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food. Food Waterborne Parasitol. 15(e00049)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Achaw B, Tesfa H, Zeleke AJ, Worku L, Addisu A, Yigzaw N and Tegegne Y: Sero-prevalence of Toxoplasma gondii and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia. BMC Infect Dis. 19(581)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Teimouri A, Nassrullah OJ, Hedayati P, Bahreini MS, Alimi R, Mohtasebi S, Salemi AM and Asgari Q: Prevalence and predictors of Toxoplasma gondii infection in psychiatric inpatients in Fars Province, Southern Iran. Front Psychiatry. 13(891603)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
S. Al-Malki E: Toxoplasmosis: stages of the protozoan life cycle and risk assessment in humans and animals for an enhanced awareness and an improved socio-economic status. Saudi J Biol Sci. 28:962–969. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chiang TY, Hsieh HH, Kuo MC, Chiu KT, Lin WC, Fan CK, Fang CT and Ji DD: Seroepidemiology of Toxoplasma gondii infection among healthy blood donors in Taiwan. PLoS One. 7(e48139)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Stepanova EV, Kondrashin AV, Sergiev VP, Morozova LF, Turbabina NA, Maksimova MS, Romanov DV, Kinkulkina MA, Lazareva AV and Morozov EN: Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia). PLoS One. 14(e0219454)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
McAuley JB: Congenital toxoplasmosis. J Pediatric Infect Dis Soc. 3 (Suppl 1):S30–S35. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
McLeod R, Lykins J, Gwendolyn Noble A, Rabiah P, Withers S, Clouser F and Boyer K: Management of congenital toxoplasmosis. Curr Pediatr Rep. 2:166–194. 2014.
|
|
15
|
Kim K and Weiss LM: Toxoplasma gondii: The model apicomplexan. Int J Parasitol. 34:423–432. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Weiss LM and Kim K: The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci. 5:D391–D405. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Grada S, Mihu AG, Petrescu C, Suciu O, Marincu I, Lupu MA and Olariu TR: Toxoplasma gondii Infection in patients with psychiatric disorders from Western Romania. Medicina (Kaunas). 58(208)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ahmad D, Mehdi S, Sayed HH, Sayed AK and Shirzad G: Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Trop Biomed. 27:476–482. 2010.PubMed/NCBI
|
|
19
|
Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O and Dubey JP: Toxoplasma gondii infection and schizophrenia: A case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int. 60:151–155. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
McConkey GA, Martin HL, Bristow GC and Webster JP: Toxoplasma gondii infection and behaviour-location, location, location? J Exp Biol. 216:113–119. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhu S: Psychosis may be associated with toxoplasmosis. Med Hypotheses. 73:799–801. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Torrey EF and Yolken RH: Schizophrenia as a pseudogenetic disease: A call for more gene-environmental studies. Psychiatry Res. 278:146–150. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Buentello E: Preliminary report on the relations between toxoplasmosis, lysergic acid & schizophrenia. Gac Med Mex. 88:693–710. 1958.PubMed/NCBI(In Spanish).
|
|
24
|
Chorlton SD: Toxoplasma gondii and schizophrenia: A review of published RCTs. Parasitol Res. 116:1793–1799. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Amouei A, Moosazadeh M, Nayeri Chegeni T, Sarvi S, Mizani A, Pourasghar M, Hosseini Teshnizi S, Hosseininejad Z, Dodangeh S, Pagheh A, et al: Evolutionary puzzle of Toxoplasma gondii with suicidal ideation and suicide attempts: An updated systematic review and meta-analysis. Transbound Emerg Dis. 67:1847–1860. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de Barros JLVM, Barbosa IG, Salem H, Rocha NP, Kummer A, Okusaga OO, Soares JC and Teixeira AL: Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. J Affect Disord. 209:59–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP and McConkey GA: The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 6(e23866)2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Henriquez SA, Brett R, Alexander J, Pratt J and Roberts CW: Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation. 16:122–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gaskell EA, Smith JE, Pinney JW, Westhead DR and McConkey GA: A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One. 4(e4801)2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Berdoy M, Webster JP and Macdonald DW: Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 267:1591–1594. 2000.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Celik T, Kartalci S, Aytas O, Akarsu GA, Gozukara H and Unal S: Association between latent toxoplasmosis and clinical course of schizophrenia-continuous course of the disease is characteristic for Toxoplasma gondii-infected patients. Folia Parasitol (Praha). 62(2015.015)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Parlog A, Schlüter D and Dunay IR: Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 37:159–170. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Parlog A, Harsan LA, Zagrebelsky M, Weller M, von Elverfeldt D, Mawrin C, Korte M and Dunay IR: Chronic murine toxoplasmosis is defined by subtle changes in neuronal connectivity. Dis Model Mech. 7:459–469. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
David CN, Frias ES, Szu JI, Vieira PA, Hubbard JA, Lovelace J, Michael M, Worth D, McGovern KE, Ethell IM, et al: GLT-1-dependent disruption of CNS glutamate homeostasis and neuronal function by the protozoan parasite Toxoplasma gondii. PLoS Pathog. 12(e1005643)2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xiao J, Prandovszky E, Kannan G, Pletnikov MV, Dickerson F, Severance EG and Yolken RH: Toxoplasma gondii: Biological parameters of the connection to schizophrenia. Schizophr Bull. 44:983–992. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mitra R, Sapolsky RM and Vyas A: Toxoplasma gondii infection induces dendritic retraction in basolateral amygdala accompanied by reduced corticosterone secretion. Dis Model Mech. 6:516–520. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rantala MJ, Luoto S, Borráz-León JI and Krams I: Schizophrenia: The new etiological synthesis. Neurosci Biobehav Rev. 142(104894)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Abdoli A: Toxoplasma gondii and neuropsychiatric diseases: Strain hypothesis. Neurol Sci. 34:1697–1698. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kano SI and Sawa A: Reply to Brune M and Theiss C: Remaining questions in the relationship between T. gondii infection and major mental illness. Mol Psychiatry. 25:4–5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Evans AK, Strassmann PS, Lee IP and Sapolsky RM: Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male long-evans rats. Brain Behav Immun. 37:122–133. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Afonso C, Paixão VB and Costa RM: Chronic Toxoplasma infection modifies the structure and the risk of host behavior. PLoS One. 7(e32489)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Goodwin DG, Strobl JS and Lindsay DS: Evaluation of five antischizophrenic agents against Toxoplasma gondii in human cell cultures. J Parasitol. 97:148–151. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, Torrey EF and Yolken RH: Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 254:4–8. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Webster JP, Lamberton PHL, Donnelly CA and Torrey EF: Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci. 273:1023–1030. 2006.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shibre T, Alem A, Abdulahi A, Araya M, Beyero T, Medhin G, Deyassa N, Negash A, Nigatu A, Kebede D and Fekadu A: Trimethoprim as adjuvant treatment in schizophrenia: A double-blind, randomized, placebo-controlled clinical trial. Schizophr Bull. 36:846–851. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Dickerson F, Boronow J, Stallings C, Origoni A and Yolken R: Toxoplasma gondii in individuals with schizophrenia: Association with clinical and demographic factors and with mortality. Schizophr Bull. 33:737–740. 2007.PubMed/NCBI View Article : Google Scholar
|
